MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Multiple Myeloma Research and Treatments
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,397 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,397 works in the cohort · of 4,299,418page 5 of 48

Labels cover 1 of 2,397 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,397 of 2,397 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Management of acute kidney injury in symptomatic multiple myeloma
Frank Bridoux, Nelson Leung, Mohamed Belmouaz, Virginie Royal, Pierre Ronco, Samih H. Nasr +1 more
2021· review· en· Kidney International· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
76
citations
aboutno affunlabeled
Novel therapies for multiple myeloma
Toshiaki Hayashi, Teru Hideshima, Kenneth C. Anderson
2002· review· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
74
citations
affunlabeled
The Tao of myeloma
Lawrence Boise, Jonathan L. Kaufman, Nizar J. Bahlis, Sagar Lonial, Kelvin P. Lee
2014· review· en· Blood· Medicine
distilled prediction:candidate · noneconsensus · none
72
citations
affunlabeled
Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)
Philippe Moreau, Tamás Masszi, Norbert Grząśko, Nizar J. Bahlis, Markus Hansson, Luděk Pour +19 more
2015· article· en· Blood· Medicine
distilled prediction:candidate · noneconsensus · none
69
citations
aboutno affunlabeled
Bortezomib (millennium pharmaceuticals).
Q. Ping Dou, Ronald H. Goldfarb
2002· article· en· PubMed· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
66
citations
affunlabeled
Phenotypic Heterogeneity in Multiple Myeloma Families
Henry T. Lynch, Patrice Watson, Stefano Tarantolo, Peter H. Wiernik, Brigid Quinn‐Laquer, Karin Isgur Bergsagel +6 more
2005· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
63
citations

How this was built: Screen · Findings · About